This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SNMX Senomyx (SNMX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Senomyx Stock (NASDAQ:SNMX) 30 days 90 days 365 days Advanced Chart Get Senomyx alerts:Sign Up Key Stats Today's Range$1.49▼$1.4950-Day Range N/A52-Week Range$0.83▼$1.71VolumeN/AAverage Volume151,720 shsMarket Capitalization$72.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSenomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.Read More… Receive SNMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter. Email Address SNMX Stock News HeadlinesDisty Technologies DYTMay 18, 2024 | morningstar.comAKD Securities Ltd Ordinary Shares AKDSLDecember 9, 2023 | morningstar.comHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.May 4, 2025 | Brownstone Research (Ad)NZ Automotive Investments Ltd (NZA)July 19, 2023 | investing.comMcKesson Inc. (MCK): Today's Featured Wholesale LaggardMarch 30, 2023 | thestreet.comFact check: Fetal tissue not in your food, drinks, experts sayFebruary 23, 2023 | usatoday.comHow to Get Stock Exposure to Gluten-Free MovementJune 2, 2022 | thestreet.comSenomyx, Inc.(SNMX)January 29, 2022 | fool.comSee More Headlines SNMX Stock Analysis - Frequently Asked Questions How were Senomyx's earnings last quarter? Senomyx, Inc. (NASDAQ:SNMX) posted its quarterly earnings data on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company earned $3.29 million during the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%. What other stocks do shareholders of Senomyx own? Based on aggregate information from My MarketBeat watchlists, some other companies that Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC) and DURECT (DRRX). Company Calendar Last Earnings8/02/2018Today5/03/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:SNMX CIK1123979 Webwww.senomyx.com Phone858-646-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,260,000.00 Net Margins-9.11% Pretax MarginN/A Return on Equity-15.80% Return on Assets-10.48% Debt Debt-to-Equity RatioN/A Current Ratio4.35 Quick Ratio3.92 Sales & Book Value Annual Sales$29.32 million Price / Sales2.46 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / Book3.82Miscellaneous Outstanding Shares48,340,000Free FloatN/AMarket Cap$72.03 million OptionableOptionable Beta1.33 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:SNMX) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senomyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senomyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.